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cos. ConClusiones: Es factible implementar los IMA en 48-72 hs, para responder 
a consultas puntuales acotadas. El perfil fue diferente al de los informes de ETS 
tradicionales. Los IMA más solicitados fueron aquellos relacionados con tecnologías 
terapéuticas, siendo el área oncológica la más frecuente.
PHP49
Following tHe western HtA Model in lAtin AMericA:  
A selF-FulFilling ProPHecy?
Kirpekar S.
Double Helix Consulting, London, UK
objeCtives: Health technology assessment in Latin America has been relatively 
more mature than other similarly developed health systems. This research explores 
the trends of development of HTA in the region to understand similarities to the 
European HTA model. It further looks at relevance of having such a model in Latin 
America, the relevance of the complexity of the methodologies and utilities used 
and finally, the implications of these trends. Methods: The study was conducted 
in Brazil, Mexico, Argentina and Columbia. Opinions of 18 stakeholders were col-
lected via telephone interviews. Respondents included senior clinical oncologists(3), 
academics(4), policy advisors(2), senior bureaucrats in the health ministries(3), senior 
members of HTA bodies(4) and senior executives from manufacturers(2). A scoring 
system was devised to plot the level of complexity and maturity of the HTA systems 
/ agencies both in Latin America and then comparing it with scores of a similar 
study across Europe and Australia. The responses around the relevance of the model 
and implications were analysed qualitatively adding perspective from the author’s 
experience in these countries. Results: The level of maturity of HTA processes in 
all the countries studied was seen to be generally high. The level of association with 
reimbursement processes was seen to vary. There was a split on the relevance of the 
European model to the Latin American context. Majority of the academics (n= 3/4) and 
members of HTA bodies (n= 2/4) felt that following highly complex European models 
was a necessary natural progression to the HTA development curve. This was not 
the observation with the rest of the stakeholders. ConClusions: There is thought 
to be a trend where there is a push by academics and HTA-related professionals 
towards making it similar to the European model, and thus increasingly complex. 
Greater international attention can be a reason, although it must be further explored.
HeAltH cAre use & Policy studies – Patient registries & Post-Marketing 
studies
PHP51
it APPlicAtion For Post MArketing drug registries
De Rosa M., Covezzoli A., Bosio M.A., Ortali M.
CINECA Interuniversity Consortium, Casalecchio di Reno, Italy
objeCtives: Establishing an active postmarketing safety surveillance and analysis 
system, used by health professionals, regulatory bodies and sponsors. Methods: 
The solution consists in making available to the entire community a set of online 
tools aimed to the data collection and analysis on innovative drugs. The introduc-
tion of online integrated environments ensures the appropriate use of drugs, help to 
monitor drug consumption and related costs and improves the real-time reporting 
of suspected adverse drug events. The surveillance system collects patients data in a 
common IT infrastructure within the same network. For 24 antineoplastic drugs the 
system provides also automatic procedures to manage the ‘risk sharing’ & ‘payment 
by result’ approach, that foresees partial or total refund of the cost sustained by 
the hospital pharmacy for the drug in case of progressive disease or unacceptable 
toxicity. Results: This presentation will illustrate the Cineca methodological IT 
approach used also by the Italian National Medicines Agency. The system has been 
used for 70 innovative drugs from eleven different drugs categories: antineoplastic, 
antidiabetics, neurological, dermatological, antiasmatics, ophtalmologic, antireu-
matics and others. More than 500.000 patients were registered by more than 900 
health structures in a timeframe of 7 years. ConClusions: The introduction of 
an online integrated environments ensures a more appropriate drug usage, help to 
monitor drug consumption and related costs and improves the real-time reporting 
of suspected adverse drug events.
HeAltH cAre use & Policy studies – Population Health
PHP52
exPloring incoMe inequAlity in selF-rePorted HeAltH stAtus in cHile 
AFter tHe HeAltH cAre reForM oF 2005
Cabieses B.1, Espinoza M.A.2
1Universidad del Desarrollo, Santiago, Chile, 2Pontificia Universidad Católica de Chile, Santiago, 
Chile
objeCtives: Chile carried out a health care system reform in 2005 aimed at reduc-
ing health and health care inequities. This study assessed whether household 
income-related inequality in adult self-reported health status (SRHS) was reduced 
after this reform. Methods: Before and after study design using the 2000 and 2009 
CASEN surveys (252 748 and 246 924 participants, respectively) we compared the 
Erreygers concentration index (CI) for SRHS (binary variable: poor= 0, fair/good= 1) 
between these two years. Factors associated with good health were explored using 
weighted logistic regression models. Decomposition analysis of the CIs by “legiti-
mate” (age, sex, marital status, number of household members) and “illegitimate” 
(income, ethnicity, rural/urban, education, occupation, type of health care provision) 
factors was conducted. Results: Results indicated that there was a significant 
concentration of fair/good SRHS favoring the rich people in Chile in both years 
(Erreygers corrected CI for bounded binary variables was 0.165 [Standard Error 0.007] 
in 2000 and 0.053 [0.002] in 2009). We standardized the 2000 and 2009 CIs to assess 
horizontal inequity and decomposed them into “legitimate” factors such as age 
and sex and “illegitimate” factors, mostly socioeconomic conditions. Despite the 
fact that the CIs are not directly comparable between 2000 and 2009, our findings 
suggest that the CI might have decreased after the reform, but good SRHS continued 
Procedimiento: Los datos usados en este estudio hacen parte de la validación del 
instrumento OTAS (Observational Teamwork Assessment for Surgery) en Colombia. 
Una observadora experta en el OTAS ingresó a las salas de cirugía y registró los 
puntajes otorgados a cada subequipo (anestesiólogos, cirujanos, enfermeros e 
instrumentadores quirúrgicos) en cinco comportamientos (comunicación, coordi-
nación, cooperación, liderazgo y conciencia situacional) para las tres fases quirúr-
gicas (pre, intra y post operatorio). Se aplicó la prueba U de Mann-Whitney, se hizo 
la corrección de Bonferroni para el alfa rechazando la hipótesis nula cuando el 
alfa era igual o menor a 0,004, manteniendo así un margen de error para el estudio 
de 5%. ResultAdos: Se encontró que los puntajes obtenidos en el OTAS fueron 
diferentes en la institución privada comparada con la pública (Z= 4,77; p= 0,0000), 
al realizar comparaciones discriminadas se encontraron diferencias significativas 
en los subequipos de anestesiología (Z= 12,17; p= 0,0000), en los comportamientos 
de liderazgo (Z= 3,56; p= 0,0004) y conciencia situacional (Z= 3,20; p= 0,001) y en las 
fases pre quirúrgica (Z= 4,41; p= 0,0000) y post quirúrgica (Z= 4,20; p= 0,0000), en 
todos estos casos los puntajes fueron mayores en los equipos de la institución 
privada. ConClusiones: Teniendo en cuenta el diseño los resultados no pueden 
ser generalizados. Los hallazgos sugieren una diferencia en algunas habilidades 
no técnicas e interacción en los equipos de salud según el tipo de institución, esto 
puede estar relacionado con cumplimiento de protocolos y mayor control de calidad 
implementados en la institución privada.
HeAltH cAre use & Policy studies – Health technology Assessment 
 Programs
PHP47
APPlicAtion oF HeAltH tecHnology AssessMent And 
PHArMAcoeconoMics in tHe decision-MAking Process in selected eu 
MeMber stAtes
Marusakova E.1, Bielik J.2
1GlaxoSmithKline Slovakia, Bratislava, Slovak Republic, 2Trencin University of Alexander Dubcek, 
Trenèín, Slovak Republic
bACkgRound: The application of Health Technology Assessment (HTA) and 
Pharmacoeconomics (PE) into real health policies in selected European countries 
(Austria, Bulgaria, Croatia, Czech Republic, Germany, Hungary, Latvia, Poland, 
Romania, Serbia, Slovakia, Slovenia, UK) was analyzed based on the outputs from 
the conference “Optimalization of Methods of PE and HTA: Importance for National 
Health Policy and Cross-Border Cooperation” (Slovakia, 10/2012). objeCtives: The 
objective of the paper was to compare the systems and to find the most transpar-
ent one based on the pre-defined criteria. Methods: The primary method used 
for the analysis was structured evaluation of the outputs from the conference. 
The other relevant information resulted from the systematic review of PUBMED, 
EMBASE and CENTRAL in years 2011-2012 extended to official websites of public 
health institutions and officially published data with the objective to select all 
papers on HTA/Pharmacoeconomics related to selected European countries. We 
evaluated 9 characteristics relevant for the decision-making process: legislative 
background, implementation, binding force, institutionalization, qualified personal 
resources availability, existed methodology/guidelines, clarity of the process, patient 
involvement in the process, and respecting the deadline of 180 days for issuing a 
decision. Results: Resulting from the analysis, of selected countries, the UK was 
shown to have the most transparent system. Germany and Austria ranked second. 
Hungary and Poland ranked third, followed by Slovakia. The least transparent sys-
tem was found in Bulgaria and Romania. ConClusions: One of the criteria was 
qualified personal resources availability that immediately discriminate systems 
in smaller central and eastern European countries. This should result in develop-
ing tailored approaches rather than copying technocratic “western” systems. The 
system prepared in Romania based on multiple criteria decision analysis principle 
could be regarded as a positive example.
PHP48
exPerienciA iniciAl con un nuevo tiPo de docuMento de evAluAción 
de tecnologíA sAnitAriA: “inForMes de MesA de AyudA”
Alcaraz A.1, Augustovski F.2, Garcia Marti S.3, Rey Ares L.3, Pichon Riviere A.4, Meza V.3, 
Lombardo J.1
1Institute for Clinical Effectiveness and Health Policy (IECS), Buenos Aires, Argentina, 2IECS -  
Instituto de Efectividad Clinica y Sanitaria, Buenos Aires, Argentina, 3Institute for Clinical 
Effectiveness and Health Policy, Buenos Aires, Argentina, 4IECS - Institute for Clinical Effectiveness 
and Health Policy, Buenos Aires, Argentina
objeCtivos: Si bien la utilización de Evaluación de Tecnologías (ETS) para la toma 
de decisiones es cada vez más utilizada en Argentina, es habitual la disociación 
entre el tiempo para la toma de decisiones cotidianas y el que demanda la reali-
zación de informes tradicionales. El Instituto de Efectividad Clínica y Sanitaria 
(IECS), una de las principales agencias de ETS de Latinoamérica, provee informes a 
instituciones públicas, de seguridad social y seguros privados. Se diseñó un nuevo 
tipo de documento orientado a responder una consulta puntual (motivada por 
un caso real), de respuesta en 48-72 hs, denominado Informe de Mesa de Ayuda 
(IMA). El objetivo es describir la experiencia del primer año y evaluar cuáles son las 
tecnologías más solicitadas como IMA por un grupo de decisores de Argentina y 
Uruguay. MetodologíAs: Descripción y análisis de las bases de datos de IMA reali-
zados por IECS. ResultAdos: Entre enero de 2011 y febrero de 2013 se realizaron 
110 IMA. El 78% de los pedidos correspondieron tecnologías terapéuticas (54% dis-
positivos, 26% procedimientos y 20% radioterapia), 15% a drogas y 7% a tecnologías 
diagnósticas. Esta distribución fue significativamente diferente a la observada 
en los informes de ETS donde se observa que el 52% de los pedidos correspondi-
eron a tecnologías terapéuticas, 34% a drogas y 14% a tecnologías diagnósticas. En 
cuanto a las áreas de interés el 17% de los IMA fueron relacionados con cáncer, 
el 14% con alteraciones neurológicas, el 12% con patologías traumatológicas, 11% 
gastrointestinal, 11% con trastornos urinarios, siguiendo en frecuencia motivos 
quirúrgicos, cardiovasculares, endocrinológicos, trastornos genéticos y oftalmológi-
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ratio: 2,43; 65-74 yrs old: 4,72%,I$ 25968, age ratio: 1,31; 75-84 yrs old: 8,45%; I$ 15471, age 
ratio: 0,78; 85+ yrs old: 14,09%, I$ 7832, age ratio: 0,39), and sex, males (47,4%) had a I$: 
22679 (M/F I$ ratio: 1,45). In 1 adm.(53% of deaths), mean cost was I$ 23 792; while ReH 
≤ 365 days (47% of deaths), I$ 13 530, cost ratio ReH/1 adm= 0,57 ; and if ReH < 30 days 
(29,5%), I$ 12354, cost ratio ReH< 30/1 adm= 0,52. ConClusions: Understanding the 
economic burden of dying helps promote better and cost-effective ways of promoting 
palliative care, old and readmitted deaths are less costly.
HeAltH cAre use & Policy studies – regulation of Health care sector
PHP56
FroM “generic scHeMe” to “brAnd-generic scHeMe”: tHe eFFect oF new 
Policy (2003-2004) on eFFiciency oF irAniAn PHArMAceuticAl industry
Hashemi Meshkini A.1, Varmaghani M.1, Yousefi M.2, Yaghoubifard S.1, Zekri H.3, 
Kebriaeezadeh A.1
1Tehran University of Medical Sciences, Tehran, Iran, 2Tarbiat-Modarres University of Medical 
Sciences, Mashhad, Iran, 3Allameh-Tabatabaee University of Human Sciences, Tehran, Iran
objeCtives: Brand-Generic scheme was implemented in Iran to improve the compe-
tition in the market. In this study we aim to assess if this new policy has had any posi-
tive effect on efficiency of Iranian pharmaceutical companies. Methods: We used 
Data Envelopment Analysis (DEA) to evaluate the relative efficiency of pharmaceutical 
companies for the years 1999-2008. The Wilcoxon matched-pairs signed-rank test and 
also sign test were used to assess the difference between mean relative efficiency of 
companies before and after policy. Results: Although the Wilcoxon matched-pairs 
signed-rank test did not show any significant difference between before and after 
new policy in term of both technical and pure (managerial) efficiency of included 
companies (Pvalue: 0.079 and 0.07, respectively) but the one–sided sign test indicated 
that only relative pure (managerial) efficiency has improved after this policy (Pvalue: 
0.031). ConClusions: The “Brand-Generic scheme” does not seem to be enough 
policy to improve efficiency of pharmaceutical companies in Iran. To achieve this aim, 
paying special attention to infrastructural requirements including non-discriminating 
and transparent laws and regulations for supporting competition, the competitive 
pricing policies, the presence of international companies in the market and full pri-
vatization of companies had to be also considered by policy makers.
PHP57
regulAting tHe Access to An AdequAte And An integrAl AssistAnce 
in brAziliAn PrivAte HeAltH PlAns
Silva F.H.C.V.
Agência Nacional de Saúde Suplementar, Rio de Janeiro, Brazil
objeCtives: To describe the main actions promoted by the The Federal Regulatory 
Agency for Private Health Insurance and Plans (ANS) to regulate the access 
of private health plans beneficiaries to an adequate and an integral assis-
tance. Methods: A retrospective analysis of data about coverage in health plans 
since ANS creation (1999) was done to identify the main actions promoted by the 
agency in this area. It included the set of rules published and ANS periodic publi-
cations. Results: A very important identified mechanism that ANS employs for 
regulating the users access to a full assistance is the elaboration of a list of medical 
procedures. This list constitutes the minimum obligatory coverage for all plans. It 
is periodically reviewed and incorporations and/or exclusions are made according 
to some precepts like: clinical evidence, epidemiological relevance, among oth-
ers. The guidelines implementation is another important instrument identified 
in this study to the improvement of private health assistance. ANS established a 
collaboration term with the Brazilian Medical Association (AMB) to develop guide-
lines, to spread and to monitor their implementation. ConClusions: The actions 
presented are the main one promoted by ANS to regulate the access to an ade-
quate and an integral assistance. They can also improve the sector efficiency along 
with the rational use of techniques and medical technologies. The instruments 
discussed will be a guide to upgrade the health plans management and their 
efficiency. The patients will have safer end more effective treatments and ANS 
keeps the balance and promotion of health in private health with a new model.
PHP58
A MediAção de conFlitos nA Ação FiscAlizAtoriA do setor de sAúde 
suPleMentAr brAsileiro
Tanaka F.H.R., Franco S.
ANS - Brazilian Private Health Regulatory Agency, Rio de Janeiro, Brazil
objetivos: Demonstrar a eficácia da utilização de meios consensuais de mediação 
de conflitos pela Administração Pública no controle e fiscalização do cumprimento 
das normas que regulam a assistência suplementar à saúde no Brasil. Métodos: 
Desde 2010, a ANS – Agência Nacional de Saúde Suplementar implementou o procedi-
mento NIP (Notificação de Investiação Preliminar), cujo objetivo é realizar a mediação 
de conflitos entre operadoras de planos de saúde e consumidores, no que tange a 
situações que envolvem negativa de cobertura assistencial. A NIP é um processo 
totalmente eletrônico, que confere maior celeridade e eficácia na resolução das rec-
lamações dos consumidores, induzindo uma melhora na relação operadora/consu-
midor. Com a NIP, as operadoras têm prazo de 5 dias para solucionar o conflito junto 
ao beneficiário e responder à ANS sobre as medidas tomadas. Após processamento na 
NIP, a reclamação pode ser finalizada por inexistência de infração, reparação de con-
duta ou encaminhada para abertura de processo administrativo, nos casos em que o 
conflito não foi resolvido. ResultAdos: Desde sua implementação, a resolutividade 
dos conflitos na NIP manteve-se acima de 70% do total de reclamações recebidas, o 
que em 2012 significou a conclusão de 42.672 das 54.412 denúncias de negativa de 
cobertura assistencial (78,4% de resolutividade). Antes de seu advento, as reclamações 
eram analisadas por meio de instituição de processo administrativo sancionador, que 
duravam, em média, 18-24 meses para sua conclusão, podendo levar ao arquivamento 
da denúncia ou lavratura de auto de infração contra a operadora. ConClusões: A 
NIP conferiu maior eficácia ao processo fiscalizatório da ANS, proporcionando maior 
to be concentrated among the rich in both years. Decomposition indicated that 
“illegitimate” factors remained large contributors to income-related inequality in 
SRHS even after the equity-centered reform of 2005. ConClusions: Findings sug-
gest that income-related inequality in SRHS might have decreased in Chile after 
the health care reform. Beyond this observed difference over time, the remaining 
inequality is still largely due to illegitimate factors that should be tackled through 
broader policies in the country.
HeAltH cAre use & Policy studies – quality of care
PHP53
PercePtion oF users oF drug distribution ProgrAM in brAzil
Carraro W.H., Mengue S.S., Haddad E.W.
Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
objeCtives: To characterize the users of access to medicines program developed 
in Brazil, known as Aqui Tem Farmácia Popular Program (PAFP), by identifying those 
users who migrated from other supply of basic medicines programs by means of a 
survey explicitly developed for this purpose. This work also seeks to evaluate the 
meeting customers’ needs by the Program and its satisfaction level. Methods: The 
survey instrument used gathering the users of Aqui Tem Farmácia Popular program 
has been applied in 15 counties from 14 Brazilian states. 1073 interviews com-
posed the sample, in 27 establishments of private pharmacies, during august 2012. 
The collection instrument was composed by three blocks: questions concerning 
the use of the PAFP and other programs of medicines supply; user’s profile infor-
mation; and identification of the medicine supplied. Results: The evaluation of 
the users migration from other programs identified that, before the PAFP, 52% of 
interviewed users was buying the medicines in the private pharmacy and more 
than 30% was using the Public Service in a Health Center of SUS, a piece of 11% 
began the treatment after the PAFP. More than 58% of users would use the service 
of the SUS if there was no PAFP. However, 36% of users reported that they would 
not use the SUS system for withdrawal of medicines. It was observed that 61% of 
users gave out to be economizing while withdrawing the medicines with gratuity 
or at a discount. ConClusions: The conducted survey made possible to character-
ize the users of PAFP showing aspects concerning the participation and the range 
of the program. Generally, it was found that the persons are satisfied and they 
reported to have saved with the program. They also pointed out the convenience 
they have with the possibility of the access to the medicine in any pharmacy with 
the PAFP.
PHP54
A nAtionwide survey on PAtient sAFety culture in JAPAn
Hirose M.1, Egami K.2, Tsuda Y.2, Honda J.2, Shima H.2
1Shimane University Hospital, Izumo, Japan, 2St. Mary’s Hospital, Kurume, Japan
objeCtives: To explore safety culture dimensions among health care professionals 
using Hospital Survey on Patient Safety Culture (HSOPSC) by developed by AHRQ 
(Agency for Healthcare Research and Quality). Methods: We surveyed nationwide 
the situation of patient safety culture in 13 hospitals (5,760 persons) allowed for 
additional costs on patient safety countermeasures under the social insurance med-
ical fee schedule. The questionnaire consists of seven unit-level aspects of safety 
culture including 24 items, three hospital-level including 11 items, and four outcome 
variables including nine items. Results: An average number of beds was 360 beds 
(63 - 1,354 beds). With regard to ownership, 13 hospitals included three municipality 
and local incorporated agency hospitals, one public hospital, two juridical person 
with social insurance hospitals, six medical corporation hospitals, and one other 
hospital. Number of all respondents was 5,118 persons (response rate: 88.9%), and 
included 295 physicians (90.8%), 2,909 nurses (95.5%), and 146 pharmacists (96.7%). 
In terms of 12 dimensions, the overall average positive response rate (RR) for the 
12 patient safety dimensions of the HSOPS was 49.2%, extremely lower than the 
average positive RR for the AHRQ data (61%). In terms of health care professionals, 
the overall average positive RR for pharmacists (46.2%) was lower than that for 
physicians and nurses (49.6% and 49.4%).With regard to pharmacists, the aver-
age positive RRs for 8 dimensions of the 12 dimensions were the lowest among 
three professionals, and three average positive RRs were the highest; Frequency of 
event reporting (pharmacists: physicians: nurses= 73.6%:53.3%:67.9%), Non-punitive 
response to error (48.8%:42.6%:40.4%), and Staffing (29.1%:27.0%:25.4%). ConClus
ions: The HSOPSC measurement provides the evidence for assessment of patient 
safety culture in Japan’s hospitals. This result that patient safety culture has been 
in a state of development, compared with the US hospitals.
PHP55
cost And quAlity oF dying in HosPitAl: results FroM tHe Argentine-
HeAltH cAre cost And utilizAtion ProJect (A-HcuP)
Insua J.T.1, Villalon R.1, Giunta D.2, Ioli P.3
1Hospital Universitario Austral, Universidad Austral, Derqui, Argentina, 2Hospital Italiando de 
Buenos Aires, Caba, Argentina, 3Hospital Privado de la Comunidad, Fundacion Medica de Mar del 
Plata, Mar del Plata, Buenos Aires, Argentina
objeCtives: Little is known about dying in Argentina, we studied costs and readmis-
sions (ReH) < 30 days of hospital dying adults. Methods: A cross sectional study of 1 
year hospital discharges, with HCUPs methods, of patients ≥ 19 yrs old. We obtained 
deaths, first admission (1 adm) and ReH ≤ 365 days and ReH < 30 days; total direct 
medical cost (TC I$), mean (I$) (SD), median I$ (Q1-Q3) discharge cost, (in I$ PPP, 2008), 
stratified by age/sex, admissions and ReH < 30 days and < 365 days. Results: Total 
mortality for ≥ 19 yrs old patients was 4,70%. Among 2137 deaths, Total cost of those 
dead in hospital, TC I$: 40 540 842 ; mean cost per discharge (I$) was 19853 (SD 45 599); 
Median cost per discharge I$ 4182; (Q1: 1452-Q3: 17730 I$), comprising 8,31 % of TC I$. 
Among 43321 discharges, TC$ of those alive, TC: 447 300 754 I$; mean cost per discharge 
($) was 10569 I$ (SD 21 217); Median cost per discharge 14 091 I$; (Q1: 2 496- Q3:10 054 
I$). Relative dead /alive I$ was 1,88 times higher. Mean discharge cost of deceased 
stratified by age group (mortality 19-64 yrs. old: 1,52%, I$ 48332, age 19-64/≥ 19 yrs old 
